VSEE HEALTH, INC. (VSEE): Nasdaq/NYSE listing notice — VSee Health receives Nasdaq bid price deficiency letter; faces multiple listing non-compliance issues

VSEE HEALTH, INC.

Nasdaq staff notified VSee on Sep 24, 2025 that common stock bid price closed below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until March 23, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
Also not in compliance with timely filing of Q1 and Q2 2025 10-Qs and minimum stockholders' equity of $2.5M.
Company intends to monitor bid price and consider options, including a potential reverse stock split.
If not cured, VSee's common stock and public warrants may be delisted from Nasdaq.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

VSEE HEALTH, INC. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

curities, including its common stock and public warrants, would be subject to delisting. In the event of such a notification, the Company may appeal the Nasdaq staff’s determination to delist its securities. As previously reported, the Company is currently not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company’s failure to timely file with the Securities and Exchange Commission (the “SEC”) its Quarterly Report on Form 10-Q for the periods ended March 31, 2025 and June 30, 2025. The Company is also not currently in compliance with Nasdaq Listing Rule 5550(b)(1) because

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

VSEE HEALTH, INC. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

sdaq Listing Rule 5250(c)(1) as a result of the Company’s failure to timely file with the Securities and Exchange Commission (the “SEC”) its Quarterly Report on Form 10-Q for the periods ended March 31, 2025 and June 30, 2025. The Company is also not currently in compliance with Nasdaq Listing Rule 5550(b)(1) because the Company’s stockholders’ equity had fallen below the $2,500,000 required minimum for continued listing as of December 31, 2024. The Company is working on remedying these deficiencies, but there can be no assurance that the Company will be eligible for the additional 180 calenda

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001185185-25-001289

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.